HCA Healthcare is the single hospital operator that Bloomberg identifies as one of "50 Companies to Watch in 2024."
"From Alphabet and BYD to Eli Lilly and Vivendi, keep an eye on these global stocks this year," the outlet proposes for the 50 companies out of the 2,000 firms assessed. Bloomberg analysts highlighted the companies as those warranting a closer look, based on "contrarian views and upcoming catalysts for change such as new leadership, asset sales or acquisitions, and plans for new products and services."
With 182 hospitals and more than 37,000 hospital beds, Bloomberg analyst Glen Losev said HCA "faces cost and revenue challenges that point to a reduction in its operating margin. Wages are increasing, especially for nurses, as are non-labor costs because of general inflation. And fewer physician visits indicate softening demand for care in areas such as elective surgeries."
HCA is tied to an estimated 5% increase to its revenue in 2024 with a market cap of $72 billion.
The company posted $47.66 billion in revenue for the first nine months of 2023 compared to $44.73 billion in the same period of 2022. Its fourth quarter earnings are due later this month.
Other healthcare companies recognized by Bloomberg as worth watching are Novo Nordisk, BeiGene, Boston Scientific and Eli Lilly. Weight loss drug possibilities drive potential for Novo Nordisk and Eli Lilly, with estimated revenue increases of 22% and 16%, respectively.